Skip to content

03759.HK

Pharmaron Beijing Co., Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 26.98
+0.22%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue15.9B14.1B12.3B11.5B10.3B
Cost of Revenue10.6B9.2B8.1B7.4B6.5B
Gross Profit5.3B4.9B4.2B4.1B3.8B
Operating Expenses
R&D Expense622.2M576.0M469.3M448.3M282.3M
SG&A Expense325.0M788.7M720.5M1.9B969.5M
General & Admin Expense(145.7M)736.5M676.1M1.6B739.4M
Selling & Marketing Expense(143.7M)52.2M44.4M252.8M230.1M
Other Expenses2.1B1.6B908.9M(66.9M)766.0M
Total Operating Expenses3.1B3.0B2.1B2.3B2.0B
Cost and Expenses13.6B12.2B10.2B9.7B8.5B
Operating Income (EBIT)2.3B1.9B2.1B1.8B1.7B
Non-Operating
Interest Income68.5M39.4M73.6M29.9M35.2M
Interest Expense201.9M192.8M243.7M182.2M167.3M
Net Interest Income(133.3M)(153.4M)(174.3M)(152.3M)(134.6M)
Other Non-Op Income/Expense(136.3M)(15.8M)(13.2M)(10.0M)(23.5M)
Non-Operating Income (excl Interest)(49.9M)(177.0M)(230.5M)(172.2M)(143.8M)
EBT (Pre-Tax Income)2.1B1.9B2.1B1.8B1.7B
Income Tax Expense421.7M357.5M377.1M256.1M314.3M
Bottom Line
Net Income1.8B1.7B1.8B1.6B1.4B
Earnings from Cont. Ops1.7B1.6B1.7B1.6B1.4B
Earnings from Discont. Ops—————
Bottom Line Net Income1.8B1.7B1.8B1.6B1.4B
Per Share
Basic EPSHK$0.99HK$0.94HK$1.01HK$1.00HK$0.90
Diluted EPSHK$0.99HK$0.94HK$1.01HK$1.00HK$0.90
Revenue Per ShareHK$8.72HK$8.00HK$6.87HK$6.51HK$5.79
Shares
Basic Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Diluted Shares Outstanding1.8B1.8B1.8B1.8B1.8B
Profitability Metrics
EBITDA2.7B3.3B3.4B2.9B2.5B
D&A359.7M1.2B1.0B927.2M696.2M
EBIT2.3B2.1B2.3B2.0B1.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026